Ikarian Capital, LLC

Position in IVA — Inventiva S.A.

CIK 1778253 DALLAS, TX

Position in IVA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$7,931,510

+$5,594,416 QoQ

Shares Held

1,429,101

+184.3% QoQ

Ownership

0.605%

of shares outstanding

% of Portfolio

1.12%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Ikarian Capital, LLC holds $653,059,812 across 106 Biotechnology names. IVA ranks #30 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TERN	Terns Pharmaceuticals, Inc.	1,456,378	$76,780,248
2	KOD	Kodiak Sciences Inc.	1,265,795	$48,252,105
3	ALMS	Alumis Inc.	1,213,548	$26,734,462
4	PCVX	Vaxcyte, Inc.	428,682	$24,910,711
5	PRAX	Praxis Precision Medicines, Inc.	71,581	$23,062,682
6	RLMD	Relmada Therapeutics, Inc.	2,688,359	$18,710,978
7	CYTK	Cytokinetics Inc	283,572	$18,690,230
8	TENX	Tenax Therapeutics, Inc.	1,017,600	$16,271,424

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,931,510	1,429,101	+184.3%	Shares	Sole	2026-05-15
2025-12-31	$2,337,094	502,601	+71.8%	Shares	Sole	2026-02-18
2023-03-31	$1,065,060	292,599	+2110.6%	Shares	Sole	2023-05-15
2022-09-30	$52,057	13,236	-15.0%	Shares	Sole	2022-11-14
2022-06-30	$88,332	15,579	0.0%	Shares	Sole	2022-08-12
2022-03-31	$177,600	15,579	+5.6%	Shares	Sole	2022-05-13
2021-12-31	$201,457	14,748	0.0%	Shares	Sole	2022-02-14
2021-09-30	$208,831	14,748	-1.7%	Shares	Sole	2021-11-15
2021-06-30	$204,525	15,000	0.0%	Shares	Sole	2021-08-18
2021-03-31	$220,500	15,000	0.0%	Shares	Sole	2021-08-18
2020-12-31	$217,500	15,000	0.0%	Shares	Sole	2021-02-12
2020-09-30	$177,300	15,000	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.